CXCL11 modulators (Rappaport)

N/A

Report date: 2025/03/18 18:16:26

Base Information

Drug NameCXCL11 modulators (Rappaport)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-X-C Motif Chemokine Ligand 11 modulators
TargetsC-X-C Motif Chemokine Ligand 11
Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRappaport Family Institute for Research in the Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesBioRap Technologies LtdRappaport Family Institute for Research in the Medical Sciences
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A